DXCM logo

DexCom, Inc. (DXCM)

Profile

Full Name

DexCom, Inc.

Ticker

NASDAQ: DXCM

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

April 14, 2005

Indexes

S&P 500,NASDAQ 100

Website

http://www.dexcom.com

Employees

10200

Key Details

Price

$83.37(-2.45%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$4.03B(+11.34% YoY)

Annual EPS

$1.42(+9.23% YoY)

PE ratio

62.22

Next earnings date

Jul 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $83.37
    DXCM price is $83.37

    30-Day Relative Volume

    0.67
    DXCM 30-day relative volume is 0.67

    Price Performance

    Price Most recent change

    -2.45%
    DXCM price was down -2.45% on Jul 11, 2025

    Price YTD change

    +7.2%
    DXCM price is up +7.2% since January 1st

    Price 1-year change

    -26%
    DXCM price is down -26% year-on-year

    Price 3-year change

    +6.3%
    DXCM price is up +6.3% over the past 3 years

    Price Range

    Price All-time high

    $164.86
    DXCM price is currently -49.43% below its historical high of $164.86

    Price 3-year low

    $57.52
    DXCM price is currently +44.94% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $32.69B
    DXCM market capitalization is $32.69 billion

    Market cap 3-year change

    +6.17%
    DXCM market capitalization is up +6.17% over the past 3 years

    Market cap All-time high

    $63.12B
    DXCM market capitalization is currently -48.21% below its historical high of $63.12 billion

    Market cap sector rank

    96.45%
    DXCM market capitalization is higher than 96.45% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -2.14%
    DXCM shares outstanding is down -2.14% year-on-year

    Shares Outstanding 3-Year Change

    -0.13%
    DXCM shares outstanding is down -0.13% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.82
    DXCM beta is 0.82

    200-day SMA

    $77.86
    DXCM price is currently +7.08% above its 200-day simple moving average

    50-day SMA

    $83.85
    DXCM price is currently -0.57% below its 50-day simple moving average

    RSI

    48.84
    DXCM 14-day relative strength index is 48.84

    Volume

    0.67
    DXCM 30-day relative volume is 0.67

    ATR

    $2.31
    DXCM average true range is $2.31

    10-day Historical Volatility

    29.52%
    DXCM 10-day historical volatility is 29.52%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $4.03B
    DXCM annual revenue is $4.03 billion

    Revenue Analysts estimate

    $4.61B
    DXCM annual revenue is currently -12.55% lower than the consensus analysts' forecast

    Revenue 1-year change

    +11.34%
    DXCM annual revenue is up +11.34% year-on-year

    Revenue Sector rank

    90.61%
    DXCM annual revenue is higher than 90.61% of companies in Healthcare sector

    EPS

    EPS

    $1.42
    DXCM annual earnings per share is $1.42

    EPS Analysts estimate

    $2.03
    DXCM annual earnings per share is currently -29.93% lower than the consensus analysts' forecast

    EPS 1-year change

    +9.23%
    DXCM annual earnings per share is up +9.23% year-on-year

    EPS Sector rank

    90.68%
    DXCM annual earnings per share is higher than 90.68% of companies in Healthcare sector

    Profit

    Gross profit

    $2.44B
    DXCM annual gross profit is $2.44 billion

    Gross margin

    60.46%
    DXCM annual gross profit margin is 60.46%

    Operating profit

    $600.00M
    DXCM annual operating income is $600.00 million

    Operating margin

    14.88%
    DXCM annual operating profit margin is 14.88%

    Net income

    $576.20M
    DXCM annual net profit is $576.20 million

    Net margin

    14.29%
    DXCM annual net profit margin is 14.29%

    Expenses

    Total expenses

    $3.43B
    DXCM annual total expenses is $3.43 billion

    Operating expenses

    $1.84B
    DXCM annual total operating expenses is $1.84 billion

    Cost of goods sold

    $1.59B
    DXCM annual cost of goods sold is $1.59 billion

    Selling, general & administrative expenses

    $1.29B
    DXCM annual SGA is $1.29 billion

    Depreciation and amortization

    $217.70M
    DXCM annual depreciation & amortization is $217.70 million

    Interest expense

    $19.00M
    DXCM annual interest expense is $19.00 million

    Income tax

    $132.80M
    DXCM annual income tax is $132.80 million

    EBIT & EBITDA

    EBIT

    $600.00M
    DXCM annual earnings before interest & taxes is $600.00 million

    EBITDA

    $600.00M
    DXCM annual EBITDA is $600.00 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.48B
    DXCM annual total assets is $6.48 billion

    Non current assets

    $2.18B
    DXCM annual long term assets is $2.18 billion

    Current assets

    $4.30B
    DXCM annual total current assets is $4.30 billion

    Cash and cash equivalents

    $606.10M
    DXCM annual cash & cash equivalents is $606.10 million

    Accounts receivable

    $1.01B
    DXCM annual accounts receivable is $1.01 billion

    Inventory

    $542.60M
    DXCM annual inventory is $542.60 million

    Liabilities

    Total liabilities

    $4.38B
    DXCM annual total liabilities is $4.38 billion

    Long term liabilities

    $1.45B
    DXCM annual total long term liabilities is $1.45 billion

    Current liabilities

    $2.93B
    DXCM annual total current liabilities is $2.93 billion

    Accounts payable

    $345.30M
    DXCM annual accounts payable is $345.30 million

    Debt

    Total debt

    $2.59B
    DXCM annual total debt is $2.59 billion

    Total debt 1-year change

    -0.25%
    DXCM annual total debt is down -0.25% year-on-year

    Long term debt

    $1.36B
    DXCM annual long term debt is $1.36 billion

    Short term debt

    $1.23B
    DXCM annual short term debt is $1.23 billion

    Equity & Capital

    Shareholders equity

    $2.10B
    DXCM annual stockholders equity is $2.10 billion

    Book value

    $2.10B
    DXCM annual book value is $2.10 billion

    Retained earnings

    $1.60B
    DXCM annual retained earnings is $1.60 billion

    Working capital

    $1.37B
    DXCM annual working capital is $1.37 billion

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $989.50M
    DXCM annual cash flow from operations is $989.50 million

    Cash from operations 1-year change

    +32.2%
    DXCM annual cash flow from operations is up +32.2% year-on-year

    Cash from investing

    -$207.50M
    DXCM annual cash flow from investing activities is -$207.50 million

    Cash from investing 1-year change

    +59.09%
    DXCM annual cash flow from investing activities is up +59.09% year-on-year

    Cash from financing

    -$734.80M
    DXCM annual cash flow from financing activities is -$734.80 million

    Cash from financing 1-year change

    -130.63%
    DXCM annual cash flow from financing activities is down -130.63% year-on-year

    CAPEX

    CAPEX

    $358.80M
    DXCM annual capital expenditures is $358.80 million

    CAPEX 1-year change

    +51.65%
    DXCM annual capital expenditures is up +51.65% year-on-year

    Free Cash Flow

    Free cash flow

    $630.70M
    DXCM annual free cash flow is $630.70 million

    Free cash flow 1-year change

    +23.21%
    DXCM annual free cash flow is up +23.21% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    60.46%
    DXCM annual gross profit margin is 60.46%

    Operating margin

    14.88%
    DXCM annual operating profit margin is 14.88%

    Net margin

    14.29%
    DXCM annual net profit margin is 14.29%

    ROA & ROE

    ROA

    9.04%
    DXCM annual return on assets is 9.04%

    ROE

    27.63%
    DXCM annual return on equity is 27.63%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    62.22
    DXCM price to earnings ratio is 62.22

    PE ratio Sector rank

    86.38%
    DXCM price to earnings ratio is higher than 86.38% of companies in Healthcare sector

    PB Ratio

    PB ratio

    14.42
    DXCM price to book ratio is 14.42

    PB ratio Sector rank

    92.89%
    DXCM price to book ratio is higher than 92.89% of companies in Healthcare sector

    PS Ratio

    PS ratio

    7.88
    DXCM price to sales ratio is 7.88

    PS ratio Sector rank

    73.46%
    DXCM price to sales ratio is higher than 73.46% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $34.37B
    DXCM enterprise value is $34.37 billion

    Enterprise value Sector rank

    96.25%
    DXCM enterprise value is higher than 96.25% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    35.25
    DXCM EV/EBITDA is 35.25

    EV/EBITDA Sector rank

    95.16%
    DXCM EV/EBITDA is higher than 95.16% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.47
    DXCM annual current ratio is 1.47

    Quick ratio

    1.28
    DXCM annual quick ratio is 1.28

    Leverage

    Debt to equity

    1.16
    DXCM annual debt to equity ratio is 1.16

    Interest coverage ratio

    31.58
    DXCM annual interest coverage ratio is 31.58

    Risk & Stability

    Piotroski F-Score

    7
    DXCM piotroski f-score is 7

    Altman Z-Score

    6.00
    DXCM altman z-score is 6.00

    Analyst ratings

    Recent major analysts updates

    Jun 16, 25 Truist Securities
    Buy
    May 30, 25 Goldman Sachs
    Buy
    May 22, 25 Citigroup
    Buy
    May 5, 25 Barclays
    Equal-Weight
    May 2, 25 Piper Sandler
    Overweight
    May 2, 25 Canaccord Genuity
    Buy
    May 2, 25 Baird
    Outperform
    Apr 10, 25 Mizuho
    Outperform
    Mar 4, 25 Citigroup
    Buy
    Feb 14, 25 Morgan Stanley
    Equal-Weight

    Institutional Ownership

    Screeners with DXCM included

    US stocks
    High Piotroski score stocks
    S&P 500 companies earnings calendar
    NASDAQ 100 companies
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    S&P 500 companies
    Stocks below analysts price target
    S&P 500 companies dividend calendar
    • What is the ticker symbol for DexCom, Inc.?
    • Does DexCom, Inc. pay dividends?
    • What sector is DexCom, Inc. in?
    • What industry is DexCom, Inc. in?
    • What country is DexCom, Inc. based in?
    • When did DexCom, Inc. go public?
    • Is DexCom, Inc. in the S&P 500?
    • Is DexCom, Inc. in the NASDAQ 100?
    • Is DexCom, Inc. in the Dow Jones?
    • When was DexCom, Inc.'s last earnings report?
    • When does DexCom, Inc. report earnings?

    What is the ticker symbol for DexCom, Inc.?

    The ticker symbol for DexCom, Inc. is NASDAQ:DXCM

    Does DexCom, Inc. pay dividends?

    No, DexCom, Inc. does not pay dividends

    What sector is DexCom, Inc. in?

    DexCom, Inc. is in the Healthcare sector

    What industry is DexCom, Inc. in?

    DexCom, Inc. is in the Medical Devices industry

    What country is DexCom, Inc. based in?

    DexCom, Inc. is headquartered in United States

    When did DexCom, Inc. go public?

    DexCom, Inc.'s initial public offering (IPO) was on April 14, 2005

    Is DexCom, Inc. in the S&P 500?

    Yes, DexCom, Inc. is included in the S&P 500 index

    Is DexCom, Inc. in the NASDAQ 100?

    Yes, DexCom, Inc. is included in the NASDAQ 100 index

    Is DexCom, Inc. in the Dow Jones?

    No, DexCom, Inc. is not included in the Dow Jones index

    When was DexCom, Inc.'s last earnings report?

    DexCom, Inc.'s most recent earnings report was on May 1, 2025

    When does DexCom, Inc. report earnings?

    The next expected earnings date for DexCom, Inc. is July 30, 2025
    On this page